MiraVista Behavioral Health Center, Holyoke, MA

MiraVista Behavioral Health Center

www.miravistabhc.care

MiraVista is a new behavioral health treatment center opening April 2021 in the former Providence Hospital in Holyoke, MA. The newly renovated center will initially provide adult psychiatric and addiction treatment and will expand capacity to include child and adolescent services by the end of the year. Our mission is to provide compassionate, effective, sustainable care for those suffering from psychiatric distress and substance abuse. We are committed to helping fill the critical need for quality behavioral care in the Pioneer Valley and are excited to open our doors this Spring.

Number of Employees: 100-250
Annual Revenue: $1-10 Million

www.miravistabhc.care
1233 Main Street
Holyoke, MA USA 01040
Phone: 413.701.2600

Similar Companies

Ritter Pharmaceuticals

Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.

Ehave

Ehave is empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis, and treatment. With Ehave Connect, Ehave’s mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems (“MHS”), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder (“ADHD”), through its collaboration with the Hospital for Sick Children (“SickKids”). Ehave Connect is also being utilized to advance the validation and optimization of medical marijuana, through its collaboration with MedReleaf. Ehave is headquartered in Toronto’s Discovery District, a hub of healthcare, innovation, and technology in Toronto, Canada.

CTOs on the Move